Personalized Cancer Medicine

Personalized Cancer Medicine

Personalized cancer medicine in India using pathology, clinically relevant biomarkers and molecular testing to guide evidence-based targeted, immune, endocrine or other cancer treatment.

✓Our healthcare experts will be by your side, helping you make the best treatment choice.

Our services are FREE and by using our services your hospital bill does not increase!

About Personalized Cancer Medicine

Personalized cancer medicine in India uses the tumour’s pathology, biomarkers and molecular features together with the patient’s stage, previous treatment, organ function and overall health to guide cancer therapy. It is not a single treatment and does not mean every patient needs broad genomic sequencing. The useful question is whether a specific test result can change an evidence-based treatment decision.

Evaluation usually begins with expert pathology review and confirmation of the cancer type and stage. Depending on the tumour, clinically relevant testing may include immunohistochemistry, FISH, PCR, next-generation sequencing (NGS), homologous-recombination or mismatch-repair testing, liquid biopsy or germline testing when inherited cancer risk is suspected. Sample quality matters: old or small biopsy material may be insufficient, and a new biopsy is sometimes required. A detected mutation is not automatically actionable; variants must be interpreted in the context of approved indications, clinical evidence and previous therapies.

Treatment may include targeted therapy, immunotherapy, endocrine therapy, chemotherapy or a clinical trial when supported by the cancer type and biomarker profile. Molecular results can also show that a proposed drug is unlikely to help. Treatment response and toxicity still require standard oncology monitoring, and repeat profiling may occasionally be useful when cancer progresses or develops resistance.

Cost in India depends on pathology review, the number and type of biomarkers tested, focused versus broad NGS, tissue versus liquid biopsy, genetic counselling when indicated, and the medicine or treatment ultimately selected. Major Indian tertiary cancer centres provide molecular pathology, genomic laboratories, medical oncology and multidisciplinary tumour boards. Medical Help India is a connection platform that can connect international patients with a suitable healthcare partner to review pathology and molecular reports, determine which additional tests are clinically useful and obtain an individual treatment and cost estimate.

What's Included

Pre-treatment consultation
Diagnostic tests & evaluation
Treatment procedure
Post-treatment care
Hospital stay (if required)
Follow-up consultations

Why consider treatment in India?

Access to experienced specialists

Advanced treatment and diagnostic options

More affordable hospital care

Shorter waiting times for treatment

Help comparing hospitals, plans and costs

Support with appointments, travel and follow-up

Cost in India

USD
On request

Final costs depend on the medical assessment, hospital, room category and clinical needs.

Get a Cost Estimate

How it works

1

Share your details

Tell us about your health concerns, age and current location.

2

Receive a call

We call you to discuss your situation, needs and questions.

3

Receive a treatment plan

Get information about the most suitable treatment plan, hospital and estimated cost.

4

Choose your plan

Review the options and agree on your care and travel plan.

5

Get full support

Receive full support throughout every stage of your care journey.

6

Receive care in India

Receive your planned care with support throughout your stay.

Top Hospitals for Personalized Cancer Medicine

View All Hospitals →

Top Doctors for Personalized Cancer Medicine

View All Doctors →

Frequently Asked Questions

How much does Personalized Cancer Medicine cost in India?

Cost depends on pathology review, focused biomarker tests versus broad NGS, tissue or liquid-biopsy testing, genetic counselling when indicated and the cancer treatment selected from the results. Molecular testing and ongoing targeted or immune therapy should be itemised separately because drug choice and duration can dominate the total cost.

Which medical reports are useful to have ready for Personalized Cancer Medicine?

Have ready: the pathology report and, if available, pathology slides or block details, the latest staging scans, oncology notes and all existing biomarker, molecular or germline genetic reports. Include previous surgery, radiotherapy and systemic-treatment summaries, current medicines, treatment response or progression information and any family cancer history relevant to hereditary testing.

What does personalized cancer medicine mean?

It uses tumour pathology, biomarkers and patient-specific factors to guide treatment choices.

Does every cancer patient need genomic testing?

No. The usefulness of molecular testing depends on cancer type, stage and whether results are likely to change treatment.

Does finding a mutation always mean there is a targeted drug?

No. Some alterations are not actionable, and treatment decisions must consider clinical evidence and approved options.

Doctor discussing treatment options with a patient

Our services are FREE

We connect you with leading hospitals and specialists in India. You pay the hospital directly.

TelegramWhatsApp